Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

29. August 2024 08:45 ET | Quelle: International Myeloma Foundation

The International Myeloma Foundation (IMF) Brings Back ‘Do You #kNOwMyeloma?’ for Blood Cancer Awareness Month 2024

LOS ANGELES, Aug. 29, 2024 (GLOBE NEWSWIRE) -- With Blood Cancer Awareness Month coming up this September, the International Myeloma Foundation (IMF) is reviving and amplifying its highly successful...
29. August 2024 05:37 ET | Quelle: Research and Markets

Respiratory Drugs - Market Insights, Competitive Landscape, and Industry Forecast to 2030; Featuring Company and Product Profiles of AstraZeneca, F. Hoffmann-La Roche, Teva Pharma, Novartis, GSK, and More

Dublin, Aug. 29, 2024 (GLOBE NEWSWIRE) -- The "Respiratory Drugs - Market Insights, Competitive Landscape, and Industry Forecast to 2030" drug pipelines has been added to ResearchAndMarkets.com's...
28. August 2024 11:07 ET | Quelle: Research and Markets

Dengue Vaccine Research Report 2024 with Focus on 40+ Players Including Biological E, GSK, Instituto Butantan, Panacea Biotec, Sanofi, Takeda, Vabiotech - Market Forecast to 2030

Dublin, Aug. 28, 2024 (GLOBE NEWSWIRE) -- The "Dengue Vaccine - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Dengue Vaccine was...
28. August 2024 09:08 ET | Quelle: Research and Markets

Over the Counter (OTC) Drugs Market Report 2024-2030: Features Strategic Company Profiles of 42 Players Including Bayer, Boehringer Ingelheim, GlaxoSmithKline, J&J, Novartis, Pfizer, Sanofi, Takeda Pharma

Dublin, Aug. 28, 2024 (GLOBE NEWSWIRE) -- The "Over the Counter (OTC) Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Over...
28. August 2024 06:03 ET | Quelle: Research and Markets

Celiac Disease Drugs Market - Global First Line of Treatment, Second Line of Treatment, Steroids & Immunosuppressive Drugs, Therapeutic Vaccines, Vitamins & Dietary Supplements Forecast 2024-2030

Dublin, Aug. 28, 2024 (GLOBE NEWSWIRE) -- The "Global Celiac Disease Drugs Market by Drug (First Line of Treatment, Second Line of Treatment), Type (Steroids & Immunosuppressive Drugs,...
28. August 2024 04:45 ET | Quelle: Research and Markets

COVID-19 Vaccines Business Research Report 2024: Doses to Reach a Projected 4.2 Billion by 2025 - Global Market Forecast to 2030

Dublin, Aug. 28, 2024 (GLOBE NEWSWIRE) -- The "COVID-19 Vaccines - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for COVID-19...
27. August 2024 10:30 ET | Quelle: Future Market Insights Global and Consulting Pvt. Ltd.

Biosimilar and Biologics Market Is Expected to Reach USD 1,060.7 Billion by 2034 And Grow at a Compound Annual Growth Rate of 7.6 % | FMI Inc.

NEWARK, Del, Aug. 27, 2024 (GLOBE NEWSWIRE) -- As per the latest analysis, the biosimilar and biologics market value is estimated to reach USD 520.9 billion in 2024. Global sales of biosimilar and...
27. August 2024 10:09 ET | Quelle: Research and Markets

United States Fabry Disease Treatment Research Report 2024: Market Size, Trends, Competition, Forecasts and Opportunities, 2019-2029

Dublin, Aug. 27, 2024 (GLOBE NEWSWIRE) -- The "United States Fabry Disease Treatment Market, By Region, Competition, Forecast and Opportunities, 2019-2029F" report has been added to ...
27. August 2024 04:04 ET | Quelle: Research and Markets

Pharma and Biotech Preclinical Stage Partnering Terms and Agreements Analysis Report and Directory 2024: Essential Benchmark Data for Dealmakers - Royalty Rates, Deal Financials, Contract Documents

Dublin, Aug. 27, 2024 (GLOBE NEWSWIRE) -- The "Global Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech 2019-2024" report has been added to ResearchAndMarkets.com's offering. ...
26. August 2024 22:48 ET | Quelle: Simtra BioPharma Solutions

Simtra BioPharma Solutions ernennt Dr. Lidia Serina zum Head of Development Services

PARSIPPANY, New Jersey, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Simtra BioPharma Solutions, ein führendes Auftragsentwicklungs- und Produktionsunternehmen (Contact Development and Manufacturing...

Vorherige Seite

Nächste Seite